RESULTS OF A PHASE II TRIAL OF AZACITIDINE (AZA) plus /- EPOETIN BETA (EPO) IN LOWER RISK MDS
HAEMATOLOGICA(2012)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined